Price
43.75
+0%52W Range
Market Cap
₹87.52 Cr
Traded: ₹0.01 Cr (0.01%) 0.0x
Free Float: ₹17.65 Cr (0.03% of FF traded)
Volume · 60D trend
1.2 K 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
RS Score
Create a free account to unlock your edge
Scanners, market pulse, FII/DII data, and TradingView charts — free forever
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Sales | -- | +21.0% | +17.0% | -- | +22.0% | Stable |
| Profit | -- | +68.0% | +54.0% | -- | +6.0% | Decelerating |
| Return | -- | -- | -- | -46.0% | -- | -- |
| ROE | -- | +31.0% | +27.0% | -- | -- | Decelerating |
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Mar 2026PDF ↗ | Sep 2025PDF ↗ | Mar 2025PDF ↗ | Sep 2024 | |
|---|---|---|---|---|
| Sales | 24 | 21 | 17 | 23 |
| Expenses | 15 | 17 | 15 | 14 |
| Operating Profit | 9 | 4 | 3 | 9 |
| Other Income | 2 | 1 | 1 | 0 |
| Interest | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 |
| Profit Before Tax | 10 | 5 | 3 | 9 |
| Tax % | 25.0% | 26.0% | -34.0% | 26.0% |
| Net Profit | 8 | 4 | 4 | 7 |
| Exceptional Items | -- | -- | -- | -- |
| EPS (Rs) | 3.8 | 1.9 | 2.1 | 4.2 |
| Sales Growth (YoY) | 41.2% | -8.7% | -- | -- |
| Sales Growth (QoQ) | 14.3% | 23.5% | -26.1% | -- |
| OP Growth (YoY) | 200.0% | -55.6% | -- | -- |
| OP Growth (QoQ) | -- | -- | -- | -- |
| Profit Growth (YoY) | -- | -- | -- | -- |
| EPS Growth (YoY) | 79.5% | -53.8% | -- | -- |
| EPS Growth (QoQ) | 95.3% | -8.1% | -49.8% | -- |
| OP Margin | 37.5% | 19.1% | 17.6% | 39.1% |
| Net Margin | 33.3% | 19.1% | 23.5% | 30.4% |
| Material Cost % | 30.8% | 28.9% | 29.8% | 27.3% |
| Employee Cost % | 17.1% | 20.0% | 21.3% | 15.1% |
| P/S | 1.94 | -- | -- | -- |
| P/E | 7.68 | -- | -- | -- |
| P/B | 1.08 | -- | -- | -- |
Exchange Filings
50Amwill Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/10/2026 ,inter alia, to consider and approve Unaudited Financial Results ....
Intimation under Regulation 30 of the Sebi (listing Obligation and disclosure Requirements) Regulations,2015- Grant of license/regulatory approval for import of folicolor-oxidative hair colour.
Certificate under Regulation 74(5) of SEBI ( Depositories and Participants) Regulations, 2018 for the 2nd Quarter ended September 30, 2026 of FY 2026-27.
Intimation of Trading Window Closure for Half Year ending September 30, 2026.
Intimation regarding Re-appointment of Manging Directors for the further term of five years pursuant to the approval of the Members at the 9th AGM of Amwill Health Care Limited.
Submission of E voting results along with consolidated Scrutinizer''s Report for the 9th AGM of Amwill Health Care Limited.
Outcome of the proceedings of 09th AGM of Amwill Health Care Limited held on August 14, 2026 .
Announcment under Regulation 30(LODR)- Change in Mangement PDf is attched.
Announcement under Regulation 30 of SEBI (LODR) Regulation, 2015 regarding investment in different segments.
Newspaper Publication - Notice of 9th Annual General Meeting of Amwill Health Care Limited , evoting and other Information
Intimation of approval for opening of fixed Deposit of Rs. 2 crores with Vysya Co-operative Bank.
Annual Report of Amwill Health Care Limited FY 2025-26
Notice of the Ninth Annual General Meeting for the Financial Year 2025-26 is attched.
Outcome Of The Meeting Of Board Of Directors Of Amwill Health Care Limited Held On July 17,2026.
The Record date for the purpose of Final Dividend For FY 2026 will be August 08, 2026.
Certificate under Regulation 74(5) of the SEBI ( DP) Regulations, 2018 for the 1st Quarter ended June 30, 2026 of FY 26-27.
Intimation of approval for investment in MO Alternates India Credit Excellence Fund - I (Category II AIF) and Goverment Securities.
Approval of audited Financial Results for half year and FY 2026
Pursuant to regulation 32 of Sebi (LODR) Regulations 2015, we here by confirm that there is no deviation or variation in utilisation of proceeds of the IPO fund from the object stated in ....
Outcome of the meeting of the Board of Directors held on May 30, 2026: Approval of Audited Financial Results for Half Year & FY 2026; recommendation of dividend @ 5%, i.e.; Rs.0.50- per ....
Declaration of Non Applicability of Annual Secretarial Compliance is attched herewith.
Amwill Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve Audited Financial Results ....
Compliance Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for 4th Quarter ended March 31, 2026 of FY 2025-26.
Please find the attached intimation under Regulation 30 of Listing Regulation.
Intimation of Trading Window Closure for the Half Year and Financial Year ending March 31, 2026.
Please find the attached intimation under Regulation 30 of Listing Regulations.
Re appointment of SPR& Co, Chartered Accountants ("SPR") as the internal Auditor of the Company for Financial Year 2025-26.
Intimation of approval for Investment in Vivriti Fixed Income Fund, a scheme of Vivriti Vihaan Trust, an Alternative Investment Fund ("AIF") registered with SEBI as a Category II AIF and ....
Compliance Certificate under Regulation 74(5) of the SEBI (Depositories and Participants ) Regulations, 2018, for 3rd Quarter ended December 31, 2025 of FY 2025-26.
A statement of Deviation or Variuation pusuant to the Regulation 32 of SEBI (LODR) Regulation, 2015 be and here by attached.
Unaudited Financial Results for the half year ended September 30, 2025, pursuant to Regulations 33 of SEBI (LODR) Regulations, 2015
Disclosure under Regulation 30 and 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (''SEBI Listing Regulations'') ....
Amwill Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2025 ,inter alia, to consider and approve the Unaudited Financial ....
Amwill Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2025 ,inter alia, to consider and approve the Unaudited Financial ....
Compliance Certificate Under Regulation 74(5) of the SEBI ( Depositories and Participants) Regulations, 2018, for 2nd Quarter ended September 30, 2025.
Intimation for Closure of Trading Window half year ending 30th September, 2025.
Amwill Health Care Limited- Scrutinizer Report and e voting Results of 08th Annual General Meeting.
Amwill Health Care Limited- Proceedings of 08th Annual General Meeting held on August 14, 2025 through Video Conferencing mode.
Newspaper Publication- Notice of 08th Annual General Meeting of Amwill Helath Care Limited , evoting Information.
Annual Report of Amwill Health Care Limited FY 25
Notice of 08th Annual General Meeting and Annual Report for FY 2024-25
Newspaper Advertisments- 08th Annual General Meeting through Video Conferencing/ other Audio- Visual Means ("VC/OAVM") facility.
Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018, for the Quarter ended June 30, 2025
The Board of Directors at its meeting held today inter-alia has considered and approved 1. Appointment of Ms. Mehak Gupta (FCS 10703, COP No. 15013), Practicing Company Secretary, Peer ....
Strategic Expansion Across Key States, New Product Launch and Strengthening Financial Position.
Pursuant to Regulation 32 of SEBI (LODR) Regulations, 2015, we here by Confirm that there is no deviation or variation in the Utilization of proceeds of the IPO from the objects stated ....
Audited Financial Results for the half year and year ended March 31,2025, pursuant to Regulations 33 of SEBI (LODR) Regulations, 2015.
i. Audited Financial Results of the Company for the Half Yearly and Financial year ended March 31, 2025. ii. Adoption Related Party Transcation Policy as per Regulation 23 of SEBI (Listing ....
Amwill Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 ,inter alia, to consider and approve Audited Finnacial Results ....
Declaration of Non Applicability of Annual secreterial Compliance is attached herewith.
Annual Reports
12025